Sadrkhah Alireza, Seebach Jörg D, Muller Yannick
Service d'immunologie et allergologie, Département des spécialités de médecine, HUG, 1211 Genève 14.
Rev Med Suisse. 2017 Apr 5;13(557):758-762.
(Mycoplasma pneumoniae Chlamydia pneumoniae) will be discussed. Classification criteria, inflammation biomarkers and progress in imaging tools will also be described. Finally, we will review the medical management including corticosteroids, aspirin and biologicals.
将讨论（肺炎支原体 肺炎衣原体）。还将描述分类标准、炎症生物标志物以及成像工具的进展。最后，我们将回顾包括皮质类固醇、阿司匹林和生物制剂在内的药物治疗。
